Search
Close this search box.

Rodrigo Morales, PhD

Grant Title:
Development of a high throughput system for screening anti-prion molecules

Location:
University of Texas, Houston, TX

Grant Year: 2022

1-26-24: Clinical Trial Announcement

1-26-24 Clinical Trial Announcement: Multiple Sites Now Open In and Outside the U.S. To learn about additional sites that have opened: Information on ION717 Clinical Trial 10-4-23 Community Statement from Ionis Pharmaceuticals 12-21-23 Clinical Trial Announcement from Ionis Pharmaceuticals

Qingzhong Kong, PhD

Grant Title:
Development of ADAM8-based Gene Therapy for CJD

Location:
NPDPSC, Case Western Reserve University

Grant Year: 2024

Dr. Matthias Schmitz

Grant Title:
Validation of a non-invasive diagnostic test for prion diseases using tear fluid

Location:
Dementia Research Unit, Dept. of Neurology in Göttingen, National Reference Center for TSE and German Center for Neuro-degenerative diseases, Germany

Grant Year: 2024

Gerold Schmitt-Ulms, PhD

Grant Title:
Bridging the pre-clinical gap for a small brain-penetrant molecule that reduces PrPC levels

Location:
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto

Grant Year: 2024

Debbie McKenzie, PhD

Grant Title:
Modulation of Toll-Like Receptor Signaling: Unveiling Neuroinflammation and Therapeutic Strategies in Creutzfeldt-Jakob Disease

Location:
University of Alberta

Grant Year: 2024

Dr. Surabhi Mehra

Grant Title:
Understanding the molecular mechanism of spontaneous prion emergence in knock-in mouse models

Location:
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto

Grant Year: 2024

Arielle Hay, Ph.D.

Grant Title:
Generating cerebral organoids from donors with sporadic Creutzfeldt-Jakob Disease

Location:
Postdoctoral Research Fellow at Rocky Mountain Laboratories, National Institutes of Health, Hamilton, Montana

Grant Year: 2024